$ News

Panbela Provides Business Update and Reports Q3 2024 Financial Results

Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript

Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center

PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024

H.C. Wainwright Remains a Hold on Panbela Therapeutics (PBLA)

Panbela Therapeutics Inc (PBLA) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...

Panbela Provides Business Update and Reports Q2 2024 Financial Results

Panbela Therapeutics, Inc. (PBLA) Q2 2024 Earnings Call Transcript

Panbela Therapeutics GAAP EPS of -$1.47 beats by $0.60

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification

H.C. Wainwright Reaffirms Their Hold Rating on Panbela Therapeutics (PBLA)

Panbela Therapeutics says DSMB recommends continuation of ASPIRE trial

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):

Panbela Therapeutics announces oral presentation at Digestive Disease Week